Various drugs, alone or in combination, including vinblastine, bleomycin, lomustine, vincristine and recently recombinant interferon-alpha and interleukin-2, have been used with varying results as palliative treatment of cutaneous melanoma [17-20]. The gene discussed is IL2; the disease is cutaneous melanoma.